The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Serum Circulating microRNA Profiling for Identification of Potential Breast Cancer Biomarkers
Open accessAbstract
MicroRNAs (miRNAs) are a class of small, non-coding RNA molecules that can regulate gene expression, thereby affecting crucial processes in cancer development. miRNAs offer great potential as biomarkers for cancer detection because of their remarkable stability in blood and their characteristic expression in different diseases. We investigated whether quantitative RT-PCR miRNA profiling on serum could discriminate between breast cancer patients and healthy controls. We performed miRNA profiling on serum from breast cancer patients, followed by construction of ROC (Receiver Operating Characteristic) curves to determine the sensitivity and specificity of the assay. We found that seven miRNAs (miR-10b, miR-21, miR-125b, miR-145, miR-155 miR-191 and miR-382) had different expression patterns in serum of breast cancer patients compared to healthy controls. ROC curve analyses revealed that three serum miRNAs could be valuable biomarkers for distinguishing BC from normal controls. Additionally, a combination of ROC curve analyses of miR-145, miR-155 and miR-382 showed better sensitivity and specificity of our assay. miRNA profiling in serum has potential as a novel method for breast cancer detection in the Mexican population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes
Zampetaki, A., Kiechl, S., Drozdov, I., Willeit, P., Mayr, U., Prokopi, M., Mayr, A., Weger, S., Oberhollenzer, F., Bonora, E., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.226357 · Cited by 1,283
Malard, F., Wolter, A. C., Marquevielle, J., Morvan, E., Ecoutin, A., Rüdisser, S. H., Allain, F. H. T., & Campagne, S. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae201 · Cited by 1,273
Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis
Kosaka, N., Iguchi, H., & Ochiya, T. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01650.x · Cited by 1,147
Altered MicroRNA Expression Confined to Specific Epithelial Cell Subpopulations in Breast Cancer
Sempere, L. F., Christensen, M., Silahtaroglu, A., Bak, M., Heath, C. V., Schwartz, G., Wells, W., Kauppinen, S., & Cole, C. N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-5019 · Cited by 574
Direct Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast Cancer
Asaga, S., Kuo, C., Nguyen, T., Terpenning, M., Giuliano, A. E., & Hoon, D. S. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.151845 · Cited by 451
Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer
Roth, C., Rack, B., Müller, V., Janni, W., Pantel, K., & Schwarzenbach, H. (2010) · Breast Cancer Research · doi:10.1186/bcr2766 · Cited by 430
Circulating microRNAs in breast cancer and healthy subjects
Zhu, W., Qin, W., Atasoy, U., & Sauter, E. R. (2009) · BMC Research Notes · doi:10.1186/1756-0500-2-89 · Cited by 359
Circulating MicroRNAs as Noninvasive Biomarkers in Breast Cancer
Cortez, M. A., Welsh, J. W., & Calin, G. A. (2012) · Recent Results in Cancer Research · doi:10.1007/978-3-642-28160-0_13 · Cited by 310
Wang, F., Zheng, Z., Guo, J., & Ding, X. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.07.021 · Cited by 307
Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer
Wang, H., Tan, G., Dong, L., Cheng, L., Li, K., Wang, Z., & Luo, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034210 · Cited by 275
A microRNA polycistron as a potential human oncogene
Goodson, S. G., Powers, S., Cordon‐Cardo, C., He, L., Hernando, E., Mu, D., Hannon, G. J., Hemann, M. T., Thomson, J. M., Hammond, S. M., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/f32k-tf55 · Cited by 260
Santarelli, D. M., Beveridge, N. J., Tooney, P. A., & Cairns, M. J. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.030 · Cited by 254
Circulating MicroRNA in inflammatory bowel disease
Paraskevi, A., Theodoropoulos, G., Papaconstantinou, I., Mantzaris, G., Nikiteas, N., & Gazouli, M. (2012) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.02.006 · Cited by 247
Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues
Hui, A. B. Y., Shi, W., Boutros, P. C., Miller, N., Pintilie, M., Fyles, T., McCready, D., Wong, D., Gerster, K., Jurisica, I., et al. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.12 · Cited by 232
MicroRNAs are exported from malignant cells in customized particles
Palma, J., Yaddanapudi, S. C., Pigati, L., Havens, M. A., Jeong, S., Weiner, G. A., Weimer, K. M. E., Stern, B., Hastings, M. L., & Duelli, D. M. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks656 · Cited by 221
Rothé, F., Ignatiadis, M., Chaboteaux, C., Haibe-Kains, B., Kheddoumi, N., Majjaj, S., Badran, B., Fayyad-Kazan, H., Desmedt, C., Harris, A. L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020980 · Cited by 217
Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls
Hu, Z., Dong, J., Wang, L.-E., Ma, H., Liu, J., Zhao, Y., Tang, J., Chen, X., Dai, J., Wei, Q., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs030 · Cited by 215
Song, M.-Y., Pan, K.-F., Su, H.-J., Zhang, L., Ma, J.-L., Li, J.-Y., Yuasa, Y., Kang, D., Kim, Y. S., & You, W.-C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033608 · Cited by 208
A panel of five circulating microRNAs as potential biomarkers for prostate cancer
Chen, Z., Zhang, G., Li, H., Luo, J., Li, Z., Chen, G., & Yang, J. (2012) · The Prostate · doi:10.1002/pros.22495 · Cited by 183
hsa-miR-191 Is a Candidate Oncogene Target for Hepatocellular Carcinoma Therapy
Elyakim, E., Sitbon, E., Faerman, A., Tabak, S., Montia, E., Belanis, L., Dov, A., Marcusson, E. G., Bennett, C. F., Chajut, A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1313 · Cited by 166
MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF
Zou, C., Xu, Q., Mao, F., Li, D., Bian, C.-X., Liu, L.-Z., Jiang, Y., Chen, X., Qi, Y., Zhang, X., et al. (2012) · Cell Cycle · doi:10.4161/cc.20598 · Cited by 141
Bockmeyer, C. L., Christgen, M., Müller, M., Fischer, S., Ahrens, P. R., Länger, F. P., Kreipe, H. H., & Lehmann, U. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1303-3 · Cited by 133
Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma
Thayanithy, V., Sarver, A. L., Kartha, R. V., Li, L., Angstadt, A. Y., Breen, M., Steer, C. J., Modiano, J. F., & Subramanian, S. (2011) · Bone · doi:10.1016/j.bone.2011.10.012 · Cited by 132
Hauser, S., Wulfken, L. M., Holdenrieder, S., Moritz, R., Ohlmann, C., Jung, V., Becker, F. O., Herrmann, E., Walgenbach‐Brünagel, G., von Ruecker, A., et al. (2012) · Cancer Epidemiology · doi:10.1016/j.canep.2012.04.001 · Cited by 102
Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers
Krutovskikh, V. A., & Herceg, Z. (2010) · BioEssays · doi:10.1002/bies.201000040 · Cited by 96
Decreased serum miR-181a is a potential new tool for breast cancer screening
Guo, L., & Zhang, Q. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1021 · Cited by 82
MiR-382 targeting of kallikrein 5 contributes to renal inner medullary interstitial fibrosis
Kriegel, A. J., Liu, Y., Cohen, B. A., Usa, K., Liu, Y., & Liang, M. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00173.2011 · Cited by 79
Differential expression of miR‐21, miR‐125b and miR‐191 in breast cancer tissue
Mar‐Aguilar, F., Luna-Aguirre, C. M., MORENO‐ROCHA, J. C., ARAIZA‐CHÁVEZ, J., Treviño, V., Rodrı́guez-Padilla, C., & Reséndez‐Pérez, D. (2012) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/j.1743-7563.2012.01548.x · Cited by 75
Self-citationmicroRNAs as peripheral blood biomarkers of cardiovascular disease
Stefano, V. D., Zaccagnini, G., Capogrossi, M. C., & Martelli, F. (2011) · Vascular Pharmacology · doi:10.1016/j.vph.2011.08.001 · Cited by 74
Bimpaki, E. I., Iliopoulos, D., Moraitis, A. G., & Stratakis, C. A. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03725.x · Cited by 64
Wang, S., Wang, L., Bayaxi, N., Li, J., Verhaegh, W., Janevski, A., Varadan, V., Ren, Y., Merkle, D., Meng, X., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301554 · Cited by 37
Cited by
Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer
Singh, R., Pochampally, R., Watabe, K., Lu, Z., & Mo, Y.-Y. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-256 · Cited by 399
Novel combination of serum microRNA for detecting breast cancer in the early stage
Shimomura, A., Shiino, S., Kawauchi, J., Takizawa, S., Sakamoto, H., Matsuzaki, J., Ono, M., Takeshita, F., Niida, S., Shimizu, C., et al. (2016) · Cancer Science · doi:10.1111/cas.12880 · Cited by 357
Circulating miRNAs: Roles in cancer diagnosis, prognosis and therapy
Cheng, G. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.09.001 · Cited by 334
MicroRNAs as Potential Biomarkers in Cancer: Opportunities and Challenges
Lan, H., Lu, H., Wang, X., & Jin, H. (2015) · BioMed Research International · doi:10.1155/2015/125094 · Cited by 330
Extracellular/Circulating MicroRNAs: Release Mechanisms, Functions and Challenges
Sohel, M. H. (2016) · Achievements in the Life Sciences · doi:10.1016/j.als.2016.11.007 · Cited by 324
Metadata
- Authors
- Mar-Aguilar, F., Mendoza-Ramírez, J. A., Malagón-Santiago, I., Espino-Silva, P. K., Santuario-Facio, S. K., Ruiz-Flores, P., Rodríguez-Padilla, C., & Reséndez-Pérez, D.
- Venue
- Disease Markers
- Publisher
- Hindawi Limited
- Published
- 2013
- Volume
- 34
- Issue
- 3
- Pages
- 163-169
- ISSN
- 0278-0240 (ISSN-L)
- 1875-8630
- OpenAlex
- W4247249962
- Cited by
- 280
- References
- 34
- FWCI
- 11.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.